Seres Therapeutics, Inc. (MCRB) at a glance

Seres Therapeutics, Inc. (MCRB) is a Healthcare company. It trades at $5.78. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (13/100).

Price
$5.78
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$5.31 to $29.98
Vestovix Score46/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
13